Add Company
Join Now

Pyros Pharmaceuticals Revenue and Competitors

License our Company Data API

Parsippany, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pyros Pharmaceuticals's estimated annual revenue is currently $10.7M per year.(i)
  • Pyros Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Pyros Pharmaceuticals has 53 Employees.(i)
  • Pyros Pharmaceuticals grew their employee count by 47% last year.

Pyros Pharmaceuticals's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Associate Director, Quality OperationsReveal Email/Phone
3
Senior Director, Quality and ComplianceReveal Email/Phone
4
Associate Director, Supply ChainReveal Email/Phone
5
Director Product DevelopmentReveal Email/Phone
6
Associate Director, Supplier Quality ManagementReveal Email/Phone
7
Sr. Manager Analytical DevelopmentReveal Email/Phone
8
Labeling & Publishing Associate ManagerReveal Email/Phone
9
Regulatory Affairs CMC ManagerReveal Email/Phone
10
Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is Pyros Pharmaceuticals?

Pyros Pharmaceuticals is a specialty pharmaceutical company focused on developing medicines for rare pediatric diseases and underserved patient populations. \n\nWe explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niche applications. Our goal is to provide high-quality, affordable and accessible alternatives for patients that need them the most.

keywords:N/A

N/A

Total Funding

53

Number of Employees

$10.7M

Revenue (est)

47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M538%N/A
#2
$6.9M5313%N/A
#3
$6.9M532%N/A
#4
$5.8M5413%N/A
#5
$15M546%N/A